Page last updated: 2024-09-03

fosamprenavir and brecanavir

fosamprenavir has been researched along with brecanavir in 1 studies

Compound Research Comparison

Studies
(fosamprenavir)
Trials
(fosamprenavir)
Recent Studies (post-2010)
(fosamprenavir)
Studies
(brecanavir)
Trials
(brecanavir)
Recent Studies (post-2010) (brecanavir)
17455371232

Protein Interaction Comparison

ProteinTaxonomyfosamprenavir (IC50)brecanavir (IC50)
Chain A, Gag-Pol polyproteinHuman immunodeficiency virus 10.0028
Chain B, Gag-Pol polyproteinHuman immunodeficiency virus 10.0028
Chain A, Gag-Pol polyproteinHuman immunodeficiency virus 10.0028
Chain B, Gag-Pol polyproteinHuman immunodeficiency virus 10.0028

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babusis, D; Bhoopathy, S; Hidalgo, IJ; Phan, TK; Ray, AS; Rhodes, GR; Robinson, KL; Strab, R; Tong, L1

Other Studies

1 other study(ies) available for fosamprenavir and brecanavir

ArticleYear
Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Adenine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Epithelium; HIV Protease Inhibitors; Humans; Hydrolysis; Indicators and Reagents; Intestinal Absorption; Mass Spectrometry; Organophosphonates; Subcellular Fractions; Tenofovir

2007